Drug Pipeline

Investigator's Choice Chemotherapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
0
Recruiting
3
Phase 3
2
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-15 NCT05652894
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With…		 overall status: "Recruiting" → "Active Not Recruiting"
Active Studies by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07226752 A Sub-study Trial of Epcoritamab vs Investigator's Choice Chemotherapy in… Diffuse Large B-Cell Lymphoma Active, Not Recruiting
NCT05652894 A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With… Metastatic Colorectal Cancer Active, Not Recruiting
NCT04628494 A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in… Diffuse Large B-cell Lymphoma Active, Not Recruiting
Sponsors Running Investigator's Choice Chemotherapy Trials
Genmab (2) Taizhou Hanzhong biomedical co. LTD (1)
Disease Areas
DLBCL (2) Colorectal Cancer (1)
Get alerts when Investigator's Choice Chemotherapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free